Surmounting GLP-1 Weight Regain: Weight Loss Following Tirzepatide Cessation With MC4R Agonist

被引：0

|

作者：

McCorkle, Courtney

Richards, Jesse

机构：

来源：

OBESITY | 2024年 / 32卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Poster-322

引用

收藏

页码：183 / 183

页数：1

相关论文

共 50 条

[1] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
Simon, Annika
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 416 - 416
[2] Obesity/Type 2 diabetes: GLP-1 agonist tirzepatide promotes weight loss
Simon, Annika
DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (01) : 27 - 28
[3] GLP-1 agonist supports weight loss
Weiß M.
MMW - Fortschritte der Medizin, 2016, 158 (2) : 71 - 71
[4] Comment on "Obesity/Type 2 Diabetes: GLP-1 Agonist Tirzepatide Promotes Weight Loss"
Blueher, Matthias
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (08) : 415 - 416
[5] Role of Dual GIP and GLP-1 Receptor Agonist, Tirzepatide in the Management of Weight Loss; A Systematic Review
Rangraze, Imran Rashid
Khan, Shehla
Wali, Adil Farooq
Menezes, Godfred
Goud, Manjunatha
Jabran, Muhammad
CURRENT DRUG SAFETY, 2024,
[6] Liraglutide, GLP-1 receptor agonist, for chronic weight loss
Moore, Katherine G.
Shealy, Kayce
Clements, Jennifer N.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 373 - 378
[7] The MC4R agonist, setmelanotide, is associated with an improvement in hypercapnic chemosensitivity and weight loss in male mice
Rivera, Athena
Framnes-DeBoer, Sarah N.
Arble, Deanna M.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2025, 332
[8] Pharmacotherapy for Weight Loss in Cirrhosis: A Case Series of GLP-1 Agonist-associated Weight Loss
Jamshed, Fatima
Do Hamden, Albert
Kelly, Maureen
Drozd, Kristine
Viana, Artur
Mehal, Wajahat
Banini, Bubu
OBESITY, 2021, 29 : 139 - 139
[9] Weight loss mechanisms with GLP-1
Holst, J. J.
DIABETES OBESITY & METABOLISM, 2010, 12 : 25 - 25
[10] Self-Medication With GLP-1 Agonist for Weight Loss: A Pilot Study
Gonzalez-Ballesteros, Luisa
Peralta-Reich, Dinabel
Gonzalez-Ballesteros, Lina
OBESITY, 2024, 32 : 210 - 210

← 1 2 3 4 5 →